MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma

Gene

Volumn 517, Issue 2, 2013, Pages 197-204

  Ni, Yang ^a   Meng, Long ^a   Wang, Liguang ^a   Dong, Wei ^a   Shen, Hongchang ^a   Wang, Guanghui ^a   Liu, Qi ^a   Du, Jiajun ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

ERK5; Esophageal cancer; MicroRNA 143; MicroRNA 145; Tumor suppressor

Indexed keywords

MICRORNA 143; MICRORNA 145; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN BCL 2;

ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 7; RAS PROTEINS;

EID: 84873745782     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.031     Document Type: Article

References (49)

1. Akagi I., et al. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis. Esophagus 2011, 24(7):523-530.
2. Akao Y., Nakagawa Y., Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol. Rep. 2006, 16:845-850.
3. Akao Y., Nakagawa Y., Kitade Y., Kinoshita T., Naoe T. Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 2007, 98:1914-1920.
4. Akao Y., Nakagawa Y., Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 2007, 26:311-320.
5. Akao Y., Nakagawa Y., Iio A., Naoe T. Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk. Res. 2009, 33:1530-1538.
6. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662.
7. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
9. Blot W.J., McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin. Oncol. 1999, 26:2-8.
10. Borralho P.M., et al. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One 2011, 6:e23787.
11. Calin G.A., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15524-15529.
12. Chang Y.C., Yeh K.T., Liu T.C., Chang J.G. Molecular cytogenetic characterization of esophageal cancer detected by comparative genomic hybridization. J. Clin. Lab. Anal. 2010, 24:167-174.
13. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
14. Chen X., et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28:1385-1392.
15. Clape C., et al. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 2009, 4:e7542.
16. Cordes K.R., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
17. Croce C.M., Calin G.A. miRNAs, cancer, and stem cell division. Cell 2005, 122:6-7.
18. Drew B.A., Burow M.E., Beckman B.S. MEK5/ERK5 pathway: the first fifteen years. Biochim. Biophys. Acta, Rev. Cancer 2012, 1825:37-48.
19. Enzinger P.C., Mayer R.J. Esophageal cancer. N. Engl. J. Med. 2003, 349:2241-2252.
20. Gratas C., et al. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res. 1998, 58:2057-2062.
21. Hollstein M.C., Metcalf R.A., Welsh J.A., Montesano R., Harris C.C. Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9958-9961.
22. Hu N., et al. Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer 2000, 27:217-228.
23. Hu N., et al. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer. Oncogene 2004, 23:852-858.
24. Jiang W., et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9026-9030.
25. Kano M., et al. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 2010, 127:2804-2814.
26. Lin T., et al. MicroRNA-143 as a tumor suppressor for bladder cancer. J. Urol. 2009, 181:1372-1380.
27. Liu L., et al. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol. Med. Report 2012, 5:753-760.
28. Liu R., et al. The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin Homolog 1. PLoS One 2012, 7:e33987.
29. Lochhead Pamela A., Gilley R., Cook Simon J. ERK5 and its role in tumour development. Biochem. Soc. Trans. 2012, 40:251-256.
30. McManus M.T. MicroRNAs and cancer. Semin. Cancer Biol. 2003, 13:253-258.
31. Mendell J.T. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005, 4:1179-1184.
32. Mizushima T., et al. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res. 2002, 62:277-282.
33. Moskaluk C.A., Hu J., Perlman E.J. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes Cancer 1998, 22:305-311.
34. Noguchi S., et al. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 2011, 307:211-220.
35. Ogawa R., et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med. Mol. Morphol. 2009, 42:102-109.
36. Pack S.D., et al. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 1999, 25:160-168.
37. Pichler M., et al. Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer. Br. J. Cancer 2012, 106:1826-1832.
38. Shih C.H., Ozawa S., Ando N., Ueda M., Kitajima M. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. Clin. Cancer Res. 2000, 6:1161-1168.
39. Suzuki H.I., et al. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
40. Szczyrba J., et al. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol. Cancer Res. 2010, 8:529-538.
41. Takagi T., et al. Decreased expression of MicroRNA-143 and -145 in human gastric cancers. Oncology 2009, 77:12-21.
42. Tanaka E., et al. The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin. Cancer Res. 2007, 13:1331-1340.
43. Tong A.W., et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther. 2009, 16:206-216.
44. Wang X., et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008, 3:e2557.
45. Wu B.L., et al. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J. Gastroenterol. 2011, 17:79-88.
46. Zhang B., Pan X., Cobb G.P., Anderson T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.
47. Zhang H., et al. microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol. Rep. 2010, 24:1363-1369.
48. Zhang Y., et al. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol. Cancer 2012, 11:23.
49. Zhu S., et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.